The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Varian Medical Systems
Travel, Accommodations, Expenses - Varian Medical Systems
A randomized phase II study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) as a bridge to transplant in hepatocellular carcinoma (HCC).
 
Francis Warren Nugent
No Relationships to Disclose
 
Krishna Gunturu
No Relationships to Disclose
 
Keith E. Stuart
Employment - Concert Pharmaceuticals (I)
Leadership - Concert Pharmaceuticals (I)
Stock and Other Ownership Interests - Concert Pharmaceuticals (I)
Honoraria - Best Doctors, Inc; UpToDate
Consulting or Advisory Role - Bayer
 
Sebastian Flacke
Consulting or Advisory Role - AngioDynamics; BTG; Guerbet; Philips Healthcare; Surefire Medical; X-act Robotics
 
Chris Molgaard
No Relationships to Disclose
 
Klaudia Hunter
No Relationships to Disclose
 
Amir Qamar
Consulting or Advisory Role - AMAG Pharmaceuticals
 
Shams Iqbal
No Relationships to Disclose
 
Frederick Gordon
Stock and Other Ownership Interests - Allegro Diagnostics
Honoraria - Abbvie; Bristol-Myers Squibb; Gilead Sciences
Consulting or Advisory Role - Abbvie; Gilead Sciences
Speakers' Bureau - Abbvie; Gilead Sciences
Research Funding - Novartis
 
Kari Galuski
Stock and Other Ownership Interests - Allurion
Honoraria - Abbvie; Bristol-Myers Squibb; Gilead Sciences
Consulting or Advisory Role - Abbvie; Gilead Sciences
Speakers' Bureau - Abbvie; Gilead Sciences
Research Funding - Novartis
 
Erin Hartnett
No Relationships to Disclose